Sorrento Therapeutics | 8-K: Current report
Nov 7, 2023 16:34 ET
Sorrento Therapeutics | 8-K: Current report
Nov 3, 2023 17:31 ET
Sorrento Therapeutics | 8-K: Current report
Oct 27, 2023 16:15 ET
Sorrento Therapeutics | 8-K: Current report
Oct 5, 2023 17:26 ET
Sorrento Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(2.6%)
Oct 5, 2023 17:22 ET
Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Sorrento Therapeutics, Inc.
Oct 5, 2023 17:16 ET
Sorrento Therapeutics | 8-K: Current report
Sep 26, 2023 16:54 ET
Sorrento Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(1.3%)
Sep 26, 2023 16:49 ET
Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Sorrento Therapeutics, Inc.
Sep 25, 2023 16:27 ET
Sorrento Therapeutics | 8-K: Current report
Sep 12, 2023 21:51 ET
Sorrento Therapeutics | 8-K: Current report
Aug 28, 2023 17:25 ET
Sorrento Therapeutics | 8-K: Current report
Aug 21, 2023 11:20 ET
Sorrento Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(43.3%)
Aug 14, 2023 20:59 ET
Sorrento Therapeutics | 10-Q: Q2 2023 Earnings Report
Aug 11, 2023 20:00 ET
Sorrento Therapeutics | 8-K: Current report
Aug 10, 2023 16:14 ET
Sorrento Therapeutics | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Aug 7, 2023 16:15 ET
Sorrento Therapeutics | 8-K: Current report
Aug 1, 2023 06:01 ET
Sorrento Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Jul 18, 2023 17:23 ET
Sorrento Therapeutics | 8-K: Current report
Jul 13, 2023 06:26 ET
Sorrento Therapeutics | 8-K: Current report
Jul 7, 2023 21:49 ET
No Data
No Data